Abstract: Diabetes mellitus is the most common endocrine disorder, affecting 16 million individuals in the United States and 200 million worldwide. Despite the use of advanced synthetic drugs for the treatment, use of herbal remedies is gaining higher importance because of synthetic drugs have drawbacks and limitations. The herbal drugs with antidiabetic activity are extensively formulated commercially because of easy availability, affordability and less side effects as compared to the synthetic antidiabetic drugs. Antidiabetic herbal formulations (AHF) are considered to be more effective for the management of diabetes. There are around 600 herbal drug manufacturers in India of which almost all manufacturers are developing AHF in addition to others. Till date, no article is published to give detailed information of the patents on AHF. Thus, this review article undertake the attempt for providing updated information on the type of diabetes and patented AHF which will enhance the existing knowledge of the researchers.
INTRODUCTION
WHO defined Diabetes mellitus as "a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia with disturbances in carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both" [1] . The effects of diabetes mellitus include long-term damage, dysfunction and failure of various organs including kidney, nerves, heart and gastrointestinal tract. It is the most common endocrine disorder world-wide with an incidence varying between 1 to 8% [2] . The global prevalence of diabetes is estimated to increase, from 4% in 1995 to 5.4% by the year 2025 [3] . Diabetes is classified into two major categories i.e., insulin dependent diabetes (Type-1) and non-insulin dependent diabetes (Type-2 diabetes). Despite the advancement in the synthetic anti-diabetic drugs in the recent past, diabetes is still remarkably not cured successfully. Treatment of diabetes is complicated due to the lack of drugs with safety and efficacy, and are incapable of sustained clinical, biochemical, and histological cure. On the contrary the herbal drugs have gained wider importance worldwide, mostly due to higher safety, less number of adverse effects and consistent blood glucose lowering capacity. In the developed countries, the use of herbal medicine for the sufferers of diabetes is encouraged by the concern about the adverse effects and cost associated with chronic use of synthetic drug. There are wide range of phytoconstituents useful in the treatment of diabetes. These include alkaloids, [4] . Among the type-2 diabetic patients, 25% uses herbal drugs, while 75% still rely on synthetic modern drugs. However, 10% of type-1 diabetic patients frequently use medicinal plants, in addition to insulin treatment [5] .
Antidiabetic herbal formulations (AHF) are considered to be more effective for the management of diabetes [6] as compared to single herbs. There are around 6000 herbal drug manufacturers in India. Till date, no article is published to give detailed information on the patented AHF. The present review gives an exhaustive account to update on the several types of diabetes and patented AHF to upgrade the existing knowledge on the prior art.
DIABETES AND ITS TYPES
Classification of diabetes into type-1 or 2 based on the clinical presentation may be difficult [7] . Diagnosis of the main forms of diabetes depends on clinical judgment based mainly on the age of the subject and the severity of insulin deficiency at presentation, as well as the presence or absence of features of the metabolic syndrome [8] . As per WHO classification in 1998, an etiological classification was chosen to subgroup diabetes mellitus into different types. [9] 
TYPE-1 DIABETES MELLITUS
Insulin-dependent diabetes (IDDM; Type I diabetes) is one of the most serious metabolic disorders, affecting approximately 1 person in 300 in the U.S., while epidemiological studies in Europe suggested that the incidence are in-creasing [10, 11] . Type-1 diabetes occurs due to permanent (95%) destructions of -cells of islets of Langerhans present in the pancreas, by an autoimmune process, or other unknown causes leading to absolute insulin deficiency. An individual with Type-1 process may be metabolically normal before the disease is clinically manifest, but the process of ß-cell destruction can be detected. On the basis of etiology it is further classified as Immune Mediated and Idiopathic one.
IMMUNE MEDIATED DIABETES
This form of diabetes is the results of a cell-mediated autoimmune destruction of the -cells in the pancreas. It is characterized by the presence of Anti-glutamic acid decarboxylase (Anti-GAD) antibodies, islet cell or insulin antibodies without processes that lead to ß-cell destruction [12] . Thus, this category of type-1 diabetes can be identified if appropriate antibody determinations are performed [13] . Some patients, particularly children and adolescents, may present with ketoacidosis as the first manifestation of the disease. Others have modest fasting hyperglycemia that can rapidly change to severe hyperglycemia or ketoacidosis in the presence of infection or other stress. Still others, particularly adults may retain residual -cell functions sufficient to prevent ketoacidosis for many years. Many such individuals with this form of type-1 diabetes eventually require insulin for survival.
IDIOPATHIC DIABETES
In some subjects with type-1 diabetes, particularly nonCaucasians, no evidence of an autoimmune disorder is demonstrable and these are classified as idiopathic type-1. Only a minority of patients with type-1 diabetes fall into this category and showed clinical symptom of episodic ketoacidosis with varying degrees of insulin deficiency between episodes. This form of diabetes is strongly inherited and it is not associated with HLA.
TYPE-2 DIABETES MELLITUS
The most common type of diabetes mellitus constituting about 90% of diabetic population and often associated with a family history of diabetes, older age, obesity and lack of exercise [14] . It is characterized by disorders of insulin action and insulin secretion, either of the two which may be the predominant feature. Both are usually present at the time when this form of diabetes is clinically manifested. The specific reasons for the development of these abnormalities are not yet known [13] . Ketoacidosis is very rare in type 2 diabetes and does not require insulin therapy. The insulin resistance occurs in this type is partly explained by the obesity that often coexists with the disease.
GESTATIONAL DIABETES MELLITUS (GDM)
Gestational diabetes is a state of carbohydrate intolerance resulting in hyperglycaemia of variable severity, with onset or first recognition during pregnancy. It does not exclude the possibility that the glucose intolerance may leads to pregnancy but has previously gone unrecognized. The definition applies irrespective of whether or not insulin is used for treatment or whether the condition persists after pregnancy [1] . Women who are known to have diabetes mellitus and who subsequently become pregnant do not have gestational diabetes but have "diabetes mellitus and pregnancy" and should be treated accordingly before, during and after the pregnancy. In the early part of pregnancy (e.g. first trimester and half of second trimester) fasting and postprandial glucose concentrations are normally lower than in normal, nonpregnant women. Elevated fasting or postprandial plasma glucose levels may well reflect the presence of diabetes that antedates pregnancy, but criteria for designating abnormally high glucose concentration at this time in pregnancy have not yet been established. The occurrence of higher than usual plasma glucose levels at this time in pregnancy mandates careful management and may be an indication for carrying out an OGTT.
OTHER SPECIFIC TYPE OF DIABETES
Many other form of diabetes are associated with monogenetic defects in -cell function and characterized by onset of hyperglycemia at an early age called as maturity-onset diabetes of the young (MODY) further, it also showed impaired insulin secretion with minimal or no defects in insulin action. [15] [16] [17] Other specific types are currently less common causes of diabetes mellitus, but the conditions in which the underlying defect or disease process can be identified in a relatively specific manner, this include Genetic defects in insulin action, such as leprechaunism Diseases of the exocrine pancreas, such as cancer of the pancreas, cystic fibrosis and fibrocalculous pancreatopathy (a form of diabetes, which was formerly classified as one type of malnutrition-related diabetes mellitus) Endocrinopathies, such as cushing syndrome, acromegaly and phaeochromocytoma Drugs or chemicals, such as steroids and thiazides Infections, such as rubella Uncommon forms of immune-related diabetes, such as the type associated with as Klinefelter Other rare genetic syndromes associated with diabetes, such as Down syndrome.
PHYTOCONSTITUENTS IN THE TREATMENT OF DIABETES MELLITUS
Many phytoconstituents isolated from plants including the compounds belongs to the class of alkaloids, glycosides, terpenoids, flavonoids are constituted as vital elements to combat diabetes mellitus. However, the use of single phytoconstituents in the treatment of diabetes is quite ineffective. Examples of some of the important phytoconstituents are described in the prior art of patent literatures. Synergistic composition for the treatment of diabetes mellitus US7641925 Bhaskaran, S., Mohan, V [19] Pharmaceutically active extracts of vitex leucoxylon, a process of extracting the same and a method of treating diabetes and inflammatory diseases therewith US7780997
Raju, G.G., et al [20] Synergistic composition for the treatment of diabetes mellitus US7736676 Bhaskaran, S., Mohan, V.
[21]
Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans US7727563 Aviram, M. [22] Synergistic composition for the treatment of diabetes mellitus US7674486 Bhaskaran, S., Mohan, V [23] Method of treating non-insulin dependent diabetes mellitus and related complications US20100292178 Young, J.
[24]
Novel anti-diabetic herbal composition, method for preparing the same and use thereof" US20090238900 Mitra, S.K., Saxena, E., Babu, U.V. [25] Methods for the treatment or prevention of Diabetes Mellitus and other metabolic imbalances" US20090252817 Hayes, K.C., Sundram, K., Sambanthamurthi, R., Tan, Y.A. [26] Anti-diabetes extract isolated from Rauvolfia vomitoria and Citrus aurantium, and methods of using same US20090041873 Campbell-tofte, J. [27] Natural herb composition for the treatment of diabetesand manufacturing method US7482030 Mansilla, A. [28] Berry preparations for treatment of diabetes and metabolic syndrome US20090176718 Ribnicky, D., Raskin, I. [29] Anti-diabetics extract isolated from Rauvolfia vomitoria and Citrus aurantium, and methods of using same US7579025 Campbell-tofte, J. [30] Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use US7416744 Rubin, I.D., Bindra, J.S., Cawthorne, M.A. [31] Natural herb composition for the treatment of diabetes and manufacturing method US20080299236 Mansilla, A. [32] Herbal product to be administered to diabetic people and process US20080206372 Agreda, N.J., Martin, P.F., Belo, M.E.W. [33] Anti-diabetics extract isolated from Rauvolfia vomitoria and Citrus aurantium, and method of using same US7429395 Campbell-tofte, J. [34] Pharmaceutically active extracts of Vitex leucoxylon, a process of extracting the same and a method of treatingdiabetes and inflammatory diseases US20080199543 Gokaraju, G.R., Gokaraju, R.R., Gottumukkala, V.S., Somepalli, V. [35] Herbal extract and compound lupinoside and its analogues as anti-diabetic type-2drugs from plant Pueraria tuberose US7276258 Dey, D., et al [36] ( 
Summary of Invention Patent Number Inventor/Assignee References
Herbal nutraceutical formulation for diabetics and process for preparing the same US7014872 Pushpangadan, P., Prakash, D. [37] Synergistic composition for the treatment of diabetes mellitus US7141254 Bhaskaran, S., Mohan, V. [38] Herbal nutraceutical formulation for diabetics and process for preparing the same US20060147561 Pushpangadan, P., Prakash, D. [39] Process and product extracted from herbal composition useful in controlling diabetes mellitus type-2 US7056539 Leko, V. [40] Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use US7033616 Rubin, I.D., Bindra, J.S., Cawthorne,M.A . [41] Method of treating diabetes type-2 US20060177530 Crea, R. [42] Synergistic composition for the treatment of diabetes mellitus US20060153937 Bhaskaran, S., Mohan, V.
[43]
Anti-diabetics extract isolated from Rauwolfia vomitoria and Citrus aurantium, and method of using same US20060115543 Campbell-tofte, J. [44] Synergistic composition for the treatment of diabetes mellitus. US20060134242 Bhaskaran, S., Mohan, V. [45] Herbal formulation US7125571 Organ, E.J., Organ, D.L [46] Compositions for diabetes treatment and prophylaxis US6949261 Chatterji, A.K. [47] Herbal extract and compound lupinoside and its analogues as Anti-diabetics type-2drugs from plant pueraria tuberose US20050153000 Dey, D., et al. [48] Method for treating type-2 diabetes with an extract of Artemisia US6893627 Ribnicky, D.M., Raskin, I.
[49]
Herb extract-based cosmeceutical cream for controlling the blood sugar level of diabetes and methods for making it US20050048144 Han, X., Liu, M. [50] Good living tea -a diabetic dietary supplement drink US20050118324 Mathew, A.M., Mathew, T.M. [51] Herbal product to be administered to diabetic individuals and the production method thereof EP1502596 Belomaluendas, E.W. [52] Dietary supplement for promoting control of blood sugar levels and associated pathology in type-2 diabetics
Antidiabetic dietetic nutritional supplement, effective against type-1 and type-2 diabetes, comprises processed material from hibiscus plants, especially okra DE202004017554 Doku, A., Gazmend, M.
[54]
Herbal compositions and methods for diabetes and weight loss management US6780440 Naguib, Y.M.A. [55] Pharmaceutical composition for the treatment of diabetes mellitus US6692777 Lee, S.Y. [56] Method for extraction and separation of vegetable antidiabetic component JP2004115421 Fukuoka, H., Miki, K. [57] Medicinal herbal compounds for the prevention and treatment of diabetes US6770307 Yoon, J., Jun, H.
[58]
( Herbal health protective and promotive nutraceutical formulation for diabetics and process for preparing the same US20030185913 Pushpangadan, P., Prakash, D. [60] Process and product extracted from herbal composition useful in controlling diabetes mellitus type-2 US20030206976 Leko, V.
[61]
Herbal composition and medicament against diabetes mellitus type-2 manufactured thereof US6576270 Leko, V.
[62]
Antidiabetic agent and diet agent JP2003012529 Yamahara, J. [63] Herbal composition and medicament against diabetes mellitus type-2manufactured thereof US20020102315 Leko, V. [64] Pharmaceutical composition for the treatment of diabetes mellitus US20020197334 Seung, Y.L. [65] Novel herbal composition for diabetes patients and a process for producing the same US20020025349 Chandrakant, K., Yadlapalli, R., Narasimha, B.
[66]
Herbal composition for diabetes and method of treatment US 6042834 Baraka, M.W. [67] Sugar imbalance and diabetes treating herbal formulation US6093403 Huo,Y.S., Lo, S.J., Winters, W.D. [68] Herbal anti-diabetic therapeutic product containing powdered Dolichos biflorus seeds US5916567 Kameswaran, N. [69] cardamomum have been satisfactorily explored for their antidiabetic activity. Several mechanisms are proposed for explaining the anti-diabetic activity of these phytoconstituents including GLP-4 inhibitor, DPP-4 inhibitors, stimulation of glucose metabolism through peripheral gluconeogenesis, and sequestration of Ca 2+ ions from the membrane of the -cells [18, 19] . An account on several patented literature instances on various types of anti-diabetic herbal formulations are depicted in the Table 1 .
ANTI-DIABETIC HERBAL FORMULATIONS (AHF) WITH MULTIPLE PHYTOCONSTITUENTS
Instead of using single phytoconstituents for the treatment of diabetes, the herbal formulations containing multiple phytoconstituents are found to be more effective under several clinical studies for reducing blood glucose level. The several compositions of AHF are mentioned provides variable pharmacological action for treatment of diabetes [70] . The multiple combinations of phytoconstituents provide synergistic action. In a US patent 7014872, Pushpangadan and Prakash described AHF containing Piper longum fruit powder, Curcuma longa rhizome powder, Chlorophytum tuberosum and Elettaria cardamomum [71] .
ANTI-DIABETIC NUTRACEUTICAL FORMULA-TIONS (ANF)
These include formulations containing a mixture of herbal extracts, constituents from animal and mineral origin to provide synergistic anti-diabetic action. In a US Patent 7153528, Malleshi et al. (2006) described nutraceutical formulation containing soy, fenugreek seed powder, cereals, milk, edible oil, mineral premix, Spice mix, Garcinia combogia etc with enhanced blood glucose lowering action against Type-2 diabetes [72] . Similarly, Massoud described in a European patent about the anti-diabetic herbal formulation containing Centaurii herba, Teraxaci radix, Urticae herba, Cichorii radix, Morus nigra [73] .
MARKETED ANTI-DIABETIC HERBAL PREPARA-TIONS
Several anti-herbal formulations are currently being marketed in India and Internationally are represented in Table 2 .
CONCLUSION
At present the prevalence of Diabetes mellitus has reached 16 million individuals in the United States and 200 million worldwide. Despite of the advancement in drug discovery to synthesize drug, use of herbal remedies are continue because of the existing synthetic drugs have several limitations and side effects. The easy availability, affordability and fewer side effects of herbal drugs with antidiabetic activity are extensively formulated commercially compared to the synthetic drugs. The researches for the herbal drugs are still in the infancy. One can look at the future of integrated medicine and hope that research in alternative medi-cine will help identify what is safe and effective rather than marginalizing, unorthodox medical claims and findings. The use of traditional/lay remedies in the sample, far from indicating fatalism or non-compliance with modern medicine. Illustrates an effort on the part of the patient to co-opt therapies that are considered efficacious in maintaining good health. Hence, the use of local therapies and their effectiveness warrants further examination.
CURRENT & FUTURE DEVELOPMENTS
Despite of the several anti-diabetic herbal and nutraceuticals formulations for diabetes treatment, the research has taken a drag towards preparing anti-diabetic herbal formulations using novel drug delivery systems for effective treatment of diabetes mellitus. Looking into the score of patent and literature it has been conceived that the area of antidiabetic treatment by herbal drugs is exploring successfully at a greater pace. This leads to many of the herbal formulation being marketed domestically as well as internationally. 
